Laboratory Corp. (LH) Reports In-Line Q2 EPS; Adjusts Q2 Outlook
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.80, in-line with the analyst estimate of $1.80. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.46 billion.
Now sees FY2013 EPS of $6.90 - $7.10, from prior expectations of $6.85 - $7.15 and the consensus of $7.09.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Now sees FY2013 EPS of $6.90 - $7.10, from prior expectations of $6.85 - $7.15 and the consensus of $7.09.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.